R. Boggs

Hazardous waste treatment facilities : modeling production with pollution as both an input and an output

R. Boggs, Robert. L. Boggs, 1997 .

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.

D. Gladman, P. Mease, K. Papp, 2013, Journal of the American Academy of Dermatology.

A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings.

H. Kan, A. Oglesby, R. Boggs, 2015, Clinical therapeutics.

Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment

R. Gniadecki, R. Pedersen, L. Mallbris, 2014, BMC Dermatology.

Pruritus and quality of life in moderate‐to‐severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study

U. Mrowietz, D. Stefanidis, R. Pedersen, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.

B. Kirkham, H. Nab, K. de Vlam, 2015, Clinical and experimental rheumatology.

Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population

Anand A. Dalal, J. Priest, D. Stempel, 2016, International journal of chronic obstructive pulmonary disease.

Long-term, continuous dosing of etanercept in patients with plaque psoriasis

K. Papp, G. Jemec, G. Krueger, 2011 .

Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial

O. FitzGerald, R. Pedersen, B. Freundlich, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

UT3 ESTIMATING HEALTH UTILITY FROM A PHYSICAL FUNCTION ASSESSMENT IN RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH ADALIMUMAB (D2E7)

N. Sengupta, R. Boggs, T. Ashraf, 2002 .